ReviewAnnals of medicine and surgery (2012)2025

Optimizing endocrine adjuvant therapy in HR+/HER2- breast cancer: supplemental strategies and innovations.

Qiping Zhuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.